Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
283M
-
Number of holders
-
80
-
Total 13F shares, excl. options
-
80.2M
-
Shares change
-
+3.59M
-
Total reported value, excl. options
-
$626M
-
Value change
-
+$33.5M
-
Number of buys
-
42
-
Number of sells
-
-27
-
Price
-
$7.80
Significant Holders of Erasca, Inc. - Common Stock (ERAS) as of Q3 2022
94 filings reported holding ERAS - Erasca, Inc. - Common Stock as of Q3 2022.
Erasca, Inc. - Common Stock (ERAS) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 80.2M shares
of 283M outstanding shares and own 28.32% of the company stock.
Largest 10 shareholders include FMR LLC (18.3M shares), ARCH Venture Management, LLC (11.1M shares), Cormorant Asset Management, LP (10.5M shares), PFM Health Sciences, LP (7.26M shares), VANGUARD GROUP INC (5.6M shares), BlackRock Inc. (4.79M shares), ALLIANCEBERNSTEIN L.P. (4.14M shares), Artal Group S.A. (3.17M shares), AH Equity Partners Bio II, L.L.C. (2.5M shares), and STATE STREET CORP (2.05M shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.